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The relationship of quality of life and distress in prostate
cancer patients compared to the general population
Der Zusammenhang von Lebensqualität und psychischer Belastung bei
Prostatakrebspatienten im Vergleich zur Allgemeinbevölkerung
Abstract
Background: The aim of this study is two-fold. The first part compares
quality of life (QoL) data of prostate cancer patients with those of a
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Material and Methods: A sample of 265 prostate cancer patients
completedboththeEuropeanOrganizationforResearchandTreatment
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the Hos- 1 Department of Medical
Psychology and Medical pital Anxiety and Depression Scale (HADS) during their stay in the hos-
pital.AtotalHADScutoffscoreof15wasusedtoindicatepsychological Sociology, University of
Leipzig, Germany distress and significant emotional concerns in patients and men of the
general population. The results of the patients were compared with
those of the general population (N=444).
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Germany Results: Prostate cancer patients reported significantly worse levels of
social and emotional functioning as well as more symptoms like insom-
nia, constipation and diarrhea compared to the general population.
Patients and men of the general population with a total HADS score
≥15 reported lower QoL in all sub-scales except for diarrhea in com-
parison to people without distress.
Discussion: Psychological distress is accompanied by lower QoL and
therefore should be taken into consideration when QoL is assessed.
Furthermore, clinicians should be trained by professionals to detect
distress in their patients and to pay more attention to their emotional
concerns, which are strongly associated with the patients’ well-being
and QoL during their stay in hospital.
Keywords: cancer, oncology, prostate, general population, quality of
life, distress
Zusammenfassung
Zielstellung: Die vorliegende Studie verfolgt zwei Ziele. Zum einen
werden Prostatakarzinompatienten und eine bevölkerungsrepräsenta-
tivealtersspezifischeVergleichsstichprobehinsichtlichihrerLebensqua-
lität verglichen und der Einfluss von krankheitsspezifischen und sozio-
demographischen Variablen untersucht. Zum anderen werden Unter-
schiede in der Lebensqualität in Abhängigkeit von der erfahrenen psy-
chischen Belastung sowohl bei Prostatakrebspatienten als auch in der
Allgemeinbevölkerung dargestellt.
Methodik: Insgesamt beantworteten 265 Prostatakarzinompatienten
beideFragebögenwährendihresstationärenKrankenhausaufenthaltes;
den European Organization for Research and Treatment of Cancer
QualityofLifeQuestionnaire(EORTCQLQ-C30)unddieHospitalAnxiety
andDepressionScale(HADS).EinHADS-Summenwertvon≥15Punkten
wurde als Indiz einer vorliegenden psychischen Belastung in beiden
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Research Article OPEN ACCESSStichproben herangezogen. Die Ergebnisse der Patienten wurden mit
denen der Allgemeinbevölkerung (N=444) verglichen.
Ergebnisse: Prostatakrebspatienten berichteten im Vergleich zur Allge-
meinbevölkerungeinsignifikantschlechteressozialesundemotionales
Funktionsniveau sowie vermehrt Symptome von Schlafstörungen, Ver-
stopfungundDurchfall.SowohlPatientenalsauchdiemännlicheAllge-
meinbevölkerungmiteinemHADS-Summenwert≥15berichteteninallen
Skalen(mitAusnahmederSymptomskalafürDurchfall)eineniedrigere
Lebensqualität im Vergleich zu Menschen ohne psychische Belastung.
Fazit: Psychische Belastung geht mit verminderter Lebensqualität in
nahezu allen Bereichen einher und sollte daher in zukünftige Untersu-
chungen,welchedieLebensqualitätbetreffen,miteinbezogenwerden.
Des Weiteren sollten klinisch tätige Ärzte sowie das Pflegepersonal
grundlegend befähigt werden, die psychischen Belastungen ihrer Pati-
enten zu erkennen, um gegebenenfalls eine Vermittlung an das profes-
sionellepsychosozialeHelfersystemzurealisierenundeineumfassende
medizinische Versorgung während des Krankenhausaufenthaltes zu
gewährleisten.
Schlüsselwörter: Onkologie, Prostata, Karzinom, Lebensqualität,
psychische Belastung, Allgemeinbevölkerung
Background
Quality of life (QoL) has become an important outcome
inmanyfieldsofcancerresearchduringthelastdecades
[1]. To the extent that an exact definition of QoL is still
missing, there is a consensual agreement that QoL is
seen as a multidimensional construct defined by at least
three sub-domains, including physical, emotional and
social aspects of well-being [2]. The necessity of the
measurement and evaluation of QoL for a better under-
standing of the impact of the disease and respective
treatment on the patients' well-being is well documented
[1], [3].
Besides the meaning of medical treatment options for
QoLoutcomeincancerpatients,inrecentyearsthefocus
of attention has also turned to psycho-social predictors,
e.g., anxiety, depression and distress, which influence or
at least correlate with the self-assessed QoL of the pa-
tients [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]. Bloch
et al. [14] and Weber et al. [15] give an overview about
a wide range of different studies with prostate cancer
patients. The results of the referred differ remarkably,
which might be due to different settings, study designs
and sample sizes. The limitations of well-being, psycho-
logical adjustment and QoL in prostate cancer patients
were usually reported in relation to the occurrence of
cancerandtreatmentrelatedsideeffects,whereurinary,
bowelandsexualdysfunctionarethemostfrequent[15].
Stark et al. [4] brought into focus the relation between
anxiety and QoL. In a sample of 178 cancer patients of
both sexes and with different cancer sites, they found
clinicallyandstatisticallysignificantdifferencesbetween
the groups with and without probable anxiety disorder
only in two dimensions of QoL: emotional function and
insomnia, whereby patients with anxiety reported worse
functioning and more insomnia. The results of Tsunoda
et al. [5] and Skarstein et al. [6] pointed in the same dir-
ection,butonlytheQoLdimensionofemotionalfunction-
ing had been evaluated in relation to anxiety, depression
and distress measured with the Hospital Anxiety and
Depression Scale (HADS). Statistically significant differ-
ences in eight sub-scales of EORTC QLQ-C30, including
physical, role, emotional and social functioning as well
as health perception, were found by Namiki et al. [7] in
men with prostate cancer, using a distress cut off of 10
points in the HADS. Similarly, Lue et al. [8] found signifi-
cant differences in the majority of all functioning and
symptom scales in dependence on anxiety or depression
in a homogeneous cancer-specific sample. The same
tendency emerged in a population of patients with mixed
cancersites[9].Otherstudiesreportedsignificantcorrel-
ations between specific sub-domains of QoL and anxiety,
depression or psychological distress in patients with dif-
ferent cancer diagnoses [10], [11], [12], [13]. The correl-
ation coefficients varied between .28 and .75. Other
studiesthatemployedquestionnairesforanxiety,depres-
sion, distress and QoL had other foci of interests and did
notputtheresultsinrelationshiptoeachother[16],[17],
[18], [19]. Concerning further predictor variables, the
findings are inconsistent. While some researchers found
older age of patients to be a predictor of better function-
ing and less symptoms in several sub-domains of QoL
[18],[20],othersdidnotdetectsuchdifferences[8],[11].
In the study of Lintz [18] et al., the only significant dif-
ference in QoL between cancer patients diagnosed less
than one year ago and those diagnosed more than one
year ago was in the symptom of fatigue, with patients
diagnosed more recently reporting more fatigue.
Some researchers examined questionnaires of QoL and
distress in the general population to make the results of
cancerpatientscomparablewiththoseofarepresentative
sample [21], [22], [23]. Conclusively, they recommend a
more detailed consideration of the results, adjusted at
leastforgenderandage.Ithasbeenreportedthatseveral
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were negatively affected in comparison to the general
population[19],[24].Rolefunction,fatigueanddiarrhea
arethesub-scalesthatwereaffectedconsistentlyinboth
studies. Another study yielded differences in more sub-
domains of QoL, but only in a descriptive way, leaving
reliability and validity of the results vague [20]. In sum-
mary, findings about the relationship between psycho-
logical distress and QoL on the one hand and the com-
parison of the results with a representative sample on
the other hand point in the same direction while remain-
inginconsistent.Thus,asystematicexaminationofthese
relationsisrequired.Furthermore,manystudiesincluded
only small groups of patients [8], [12], [17], [19], [24],
so the generalizability of the results is limited. Therefore
the question is, to what extent is the relation between
QoL and psychological distress a cancer specific phe-
nomenon or rather a general relationship among human
beings?
The aim of this study is two-fold. The first part compares
EORTCQLQ-C30datainalargeandhomogeneousgroup
of prostate cancer patients with the general population
and analyzes the influence of cancer related as well as
socio-demographic parameters. Secondly, differences in
QoL in dependence on the experienced psychological
distress will be shown both in prostate cancer patients
and in the general population.
Material and methods
Study design
Between July 2007 and September 2008, 340 prostate
cancerinpatientswereeligibleforthisstudyintheUniver-
sity Hospital Leipzig – Department of Urology (Germany).
Patients were invited to participate in this study and to
answer the questionnaires if they had histologically
proven carcinoma, were able to understand and read
German well enough to answer the questionnaires, were
at least 18 years old and had given informed consent.
Questionnaires
Beside the socio-demographic and cancer related par-
ameters, the core questionnaires used were the cancer-
specific EORTC QLQ-C30 and the HADS. These question-
naireshavebeenvalidatedbothinthegeneralpopulation
[21],[22],[23],[25]andincancerpopulations[26],[27].
The EORTC QLQ-C30 was designed for quality of life
evaluationincancerpatients[26].Itconsistsof30items
and incorporates five functioning scales (physical, role,
emotional, social and cognitive), three symptom scales
(fatigue, pain and nausea/vomiting), a global health
status/QoLscaleandsixsingleitems(dyspnoea,appetite
loss, insomnia, constipation, diarrhea and financial dif-
ficulties). The scoring of the EORTC QLQ-C30 was per-
formed according to the EORTC scoring manual [28]. All
scores were linearly transformed into a 0–100 scale.
Higher functioning scores represent better function-
ing/QoL,whereashighersymptomscoresrepresentmore
severe symptoms. In case of missing items, the value
was replaced with the rounded mean of the remaining
items of the corresponding sub-scale when at least half
the items of the scale were answered. In addition to the
different functioning scales, a general functioning score
was calculated by the mean of all functioning scales.
Corresponding to that, a general symptom score was
calculated too. According to Osoba [1], differences of
5–10 points are considered to be clinically meaningful,
indicatingasmallchange,whereasdifferencesof10–20
points indicate a moderate change.
The Hospital Anxiety and Depression Scale (HADS) [29]
isoneofthemostcommonlyusedinstrumentsworldwide
forscreeningclinicallysignificantanxiety,depressionand
distress in patients with somatic illness. The self-admin-
istered scale consists of two sub-scales, anxiety and de-
pression, with seven items each which are rated on a
four-pointLikertscale.Thescoresofeachsub-scalerange
from 0 to 21. It has been shown that a total score ≥15 is
indicative of clinically significant distress [25], [30], [31],
[32].
Externalcomparisonwithreferencedata
To compare the results of the study population with the
Germangeneralpopulation,theage-andgender-matched
EORTCQLQ-C30datapublishedbySchwarzandHinz[23]
as well as the age- and gender-matched HADS data pub-
lished by Hinz and Schwarz [25] were used. From the
original samples of the representative surveys (N=889
[23], N=895 [25]), which were obtained using the ran-
dom-route-technique, a partial sample (N=444) was se-
lected in such a way that the mean age (63.76 years,
SD=7.9, range 51–90) corresponds to that of the study
population (63.82 years, SD=6.4, range 50–79). In add-
ition, only complete data sets of both of these question-
naires were taken into further consideration.
Furthermore,bothpopulationsandtheirEORTCQLQ-C30
resultsweresplitintotwogroupsdependingontheHADS
sum score cut off (<15 or ≥15).
Statistical methods
The statistical analysis of the data was conducted with
the SPSS 15.0 software.
Mean scores as descriptive measures were used to en-
able comparisons between prostate cancer patients and
the German general population. To examine differences
for statistical significance, the t-test was used. To reduce
the risk of spurious significant associations in multiple
comparisons,weadjustedthelevelofsignificanceaccord-
ing to Bonferroni. Referring to the 15 sub-scales of the
EORTC QLQ-C30, the adjusted p-value for statistical sig-
nificance was set to 0.05/15=0.003. Additionally, an
analysis of variances with two factors was employed to
provide information on the independent associations of
prostate cancer status and distress with quality of life.
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For this procedure the same algorithm of Bonferroni cor-
rection was used. Only patients with complete data sets
of both of these questionnaires were included in the
statistical procedure.
Results
Patients
Finally, 265 (77.9%) out of 340 eligible inpatients took
partinthisstudy.Thegroupofnon-respondentsconsisted
of 36 patients (10.6%) refusing to take part; 9 patients
(2.7%) refused to take part because they felt too much
distress and 30 patients (8.8%) had too many missing
values (more than half the items of a scale) in at least
oneofthequestionnaires.Thegroupofnon-respondents
was on average two years older and included more pa-
tients with tumor stage IV compared to the participants
of the study. Further socio-demographic and oncological
characteristics of participants and non-respondents are
summarized in Table 1.
Quality of life of patients compared to
the general population
Datashowsignificantlydiminishedvaluesinthedomains
ofemotionalandsocialfunctioningintherangeof13–15
points for the prostate cancer patients compared to the
general population. Results are shown in Table 2.
Regarding the level of experienced symptoms, prostate
cancer patients reported more insomnia, constipation
and diarrhea as well as financial difficulties. Differences
range from 5 to 7 points. There is an inverse difference
in pain, where prostate cancer patients reported signifi-
cantly less pain with a discrepancy of 5 points.
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anddependentonage,tumorstage,educationandtimesince
diagnosis (standard deviations in parentheses)
Predictors of QoL in prostate cancer
patients
Age
The study population was divided into two age groups by
the cut off of the approximate median, which was 65
years.Table2presentsmeanscoresforbothagegroups.
The only significant difference emerged in the domain of
financialdifficulties,withadiscrepancyof11points,with
more financial concerns for the patients ≤65 years old.
Tumor stage
Four tumor stages were defined on the basis of the TNM
classificationsystem[33],usingthecompleteinformation
of Tumor size, Nodes and Metastases in this categoriza-
tion.Eachgroupwithinthesametumorstageisashomo-
geneous as possible concerning the survival rate. In the
group of the study population there was no patient with
tumor stage I, and the number of patients with tumor
stage III and IV was very small in comparison to stage II.
Therefore,tumorstagesIIIandIVwereclassifiedintoone
groupandcomparedtostageII.Nostatisticallysignificant
differences were found between the groups of different
tumor stages in all scales of the EORTC QLQ-C30.
Education
Two subgroups were constituted based on years of edu-
cation, specifically 10 years or less and more than 10
years. No statistically significant differences were found
in the sub-scales except financial difficulties. Patients
with an education time of 10 years or less scored on
average 12 points higher than patients with more than
10 years of education (Table 2).
Time since diagnosis
The study group was split into two groups. One group of
patients was informed about the diagnosis up to two
months prior. The other group was informed more than
two months prior. No significant differences emerged in
the sub-scales.
Differences in QoL depending on
experienced psychological distress
Mean HADS values were 9.8 (SD 7.1) for prostate cancer
patients and 10.3 (SD 6.5) for the general population.
The t-test revealed no significant difference (T=–1.05,
p=.29). A HADS cut off score of 15 was chosen to select
patients and men in the representative sample with clin-
ically significant distress. A total of 56 patients (21.1%)
and 108 men of the general population (24.3%) had a
HADS score ≥15. Differences in the distribution of HADS
cases versus non-cases in both samples were examined
withaχ
2-testandrevealednosignificance(χ
2=.93,p=.34).
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To provide information on the independent associations
of prostate cancer status and distress with the different
quality of life domains of the EORTC, ANOVAs with two
factorswereconducted.QoLwascomparedbetweenthe
corresponding subgroups with and without experienced
distress. Results are shown in Table 3.
The distress factor had the strongest main effect on all
EORTC sub-scales. Men of both samples with a HADS
score ≥15 showed decreased levels of functioning and
Global health/QoL and increased symptom scores in all
domains except for diarrhea. These differences were
clinically meaningful in most sub-scales. The main effect
ofthesecondfactor(patientsversusgeneralpopulation)
was significant in three functioning and four symptom
scales. Patients reported lower functioning and more
symptoms except for the pain scale. The impact of the
interaction term (sample X distress) is significant only for
the diarrhea sub-scale. Compared with the main effects
on the level of diarrhea, this interaction effect is quite
small.
Means of cumulated functioning and symptom scores
depending on HADS category and sample are presented
in Figure 1 and Figure 2.
Parallellinesindicatethatthereisnointeractionbetween
sampleanddistressconcerningfunctioningandsymptom
scales. However, the main effects of the single factors
are evident. Differences between distressed and non-
distressed persons are greater (functioning score: crude
difference=diff=20–23; symptom score: diff=14) than
between prostate cancer patients and the general popu-
lation (functioning score: diff=7–10; symptom score:
diff=2–3).
Discussion
To our knowledge, this is the first study that compares
QoL of a large homogeneous sample of prostate cancer
patients with the general population in relation to the
psychological distress experienced in both groups. The
aimofthisstudywastwo-fold.Firstly,ourresultsindicate
that there is a substantial decrease in several aspects of
QoL of prostate cancer patients compared to the general
population. This concerns the domains of emotional and
social functioning as well as symptoms like insomnia,
diarrhea and constipation – and financial difficulties, if
only mean values are considered. These results differ
from those of Frojd et al. [19] and Larsson et al. [24],
regarding the specific sub-scales that are affected.
Nevertheless we confirm a general decline in QoL.
Secondly,ifwetakeintoaccounttheinfluenceofpsycho-
logical distress, a more sophisticated overall picture
emerges. In general, prostate cancer patients did not re-
port higher levels of psychological distress compared to
the general population. This is in line with other studies
and possibly due to a less invasive treatment and a relat-
ive good prognosis [34], [35]. In this study, we provide
evidence that the experienced psychological distress is
strongly associated with the self-rated QoL. Prostate
cancer patients and men of the general population that
are distressed reported worse functioning and more
severesymptomsthanbothgroupswithoutdistress.This
regards all sub-scales of the EORTC QLQ-C30 except for
diarrhea.Thedifferencesbetweenthesegroupsincrease
to more than 20 points in the different sub-scales, e.g.
the Global health/QoL, role functioning, fatigue and in-
somnia,wherebyespeciallytheenhancedlevelofinsom-
nia might reflect individual psycho-social concerns. In
general, the findings of our study provide support for
previous results [4], [5], [6], [8], [9]. Furthermore, there
aregreaterdifferencesbetweenpatientsandthegeneral
population in the group of distressed men. Namiki et al.
[7] found restrictions in more sub-domains of QoL of
prostate cancer patients. This might be due to the lower
distress cut off they used.
Insummary,theanalysisofvarianceswithtwodichotom-
ous factors, namely the sample group (patients versus
general population) and the distress group (yes versus
no), leads to the following conclusion. Self-rated QoL is
to a greater extent associated with the experienced dis-
tressandtoalesserextentassociatedwiththeexistence
of a prostate cancer diagnosis. Thus, the reported sig-
nificant associations in the literature between psycho-
logical distress and QoL [4], [5], [6], [7], [8], [9], [10],
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Figure 2: Means of symptom scores depending on HADS score and sample
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withtheresultsofthisstudy.However,theseassociations
are not specific for cancer patients. In the general popu-
lation the associations are similar. This might be due to
a partial overlapping of the constructs measured in this
study. Furthermore, due to the cross-sectional study
design, we cannot constitute conclusive evidence
whether distress causes lower QoL or vice versa. Never-
theless,somedomainsofQoLinprostatecancerpatients
are negatively affected compared to the general popula-
tion.
Contrary to that, prostate cancer patients who are dis-
tressed reported substantially less pain than the corres-
ponding sample of the general population. The reason
for that remains vague. On the one hand prostate cancer
in the first stages is not very painful. On the other hand
we have to act on the assumption that patients were
under appropriate pain medication. But why this differ-
ence emerges only in the group of the distressed is not
clear.
Among the potential predictors of QoL, the results of this
study indicate that neither education and age nor the
tumor stage predict QoL, with the exception of financial
difficulties. Cancer patients in general are faced with a
higher risk for financial difficulties than the general pop-
ulation, especially later in the course of the treatment,
when they are younger than 65 and had less than 10
years of education. This is probably due to the higher
socio-economicstatusofthebettereducatedpeopleand
to the discontinuation of their salary during the acute
phase of cancer and treatment in the group of active
population. These findings on the predictors support the
results of Lue et al. [8] and Bang et al. [11].
The main limitation of this study is its cross-sectional
design. A longitudinal design might be better suited to
exploreindicationsofcausalrelationshipsandwouldhelp
to display changes of distress and QoL over time. In
addition, the Bonferroni correction of the α-level for mul-
tiple comparisons among the potential predictors of QoL
is very conservative and might have caused spuriously
non-significant results. Thus, it is possible that some of
the mean differences really exist but did not reach the
level of significance. Another limitation refers to the gen-
eralizability of the study results. The sample mostly con-
sisted of patients that have had surgery as the main in-
tervention.Ontheonehandthisreflectsahomogeneous
sub-groupofprostatecancerpatients.Ontheotherhand
the sample is not representative of all prostate cancer
patients. Further studies could also include the prostate-
specific module of the EORTC questionnaire to obtain
more detailed results.
In summary, we have to state that QoL in prostate cancer
patients is associated to a greater extent with the ex-
perienced distress and emotional concerns and to a
lesser extent by the physical impairment from the cancer
itself. The results support this perspective, because pro-
state cancer patients without distress have better func-
tioningscoresandlowersymptomlevelsthanmenofthe
general population with distress except for the scores in
the diarrhea scale. Thus, the well documented relation-
ship of distress and QoL [4], [5], [6], [7], [8], [9], [10],
[11], [12], [13] is not only cancer-specific, but also valid
forthegeneralpopulation,andshouldthereforebetaken
into account when QoL in general is considered.
Inthefuture,cliniciansshouldbetrainedbyprofessionals
to detect distress in their patients and to pay more atten-
tion to their emotional concerns, which are closely con-
nected with the patients' well-being and QoL during their
stay in hospital. The realization of screening tests, fol-
lowedbyoffersofpsycho-socialconsultationsinthecase
of positive results, an adequate preparation for the
treatment and a trustful relationship between patients
and the medical staff can help reduce the distress of
patients. Further studies including psychological param-
eters in the research of QoL are required.
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